All PDFs presented on this website are unchanged to what has previously been published on the IPAC-RS website.

Programme of the workshop.


Individual Presentations:

- New delivery technologies for orally inhaled products (OIPs), Hugh Smyth, University of Austin, Texas

- New inhaler monitoring technologies, what they do and how they are used, Paul Colthorpe, Global Program Lead TeleHealth, Novartis Pharma

- User perspectives on innovation in inhalers, Maureen George, Columbia University, School of Nursing

- FDA CDER perspective on new technologies in inhaler products, Irene Chan, FDA CDER

- FDA CDRH perspective on new technologies in inhaler products, Linda Ricci, FDA CDRH

- Update from ISO working group on device change management, Paul Jansen, ISO WG

- Challenges in the design and manufacturing of OIPs in the new technology world, Herbert Wachtel, Boehringer Ingelheim

- Globally divergent regulatory strategies for OIPs, Anders Fuglsang, Fuglsang Pharma

- Industry view on challenges with novel devices, Stéphane Baronnet, AstraZeneca

- US and European regulatory considerations on cybersecurity and patient privacy for digital-health technologies, Katherine E. Armstrong, Drinker, Biddle & Reath LLP